Xanthoma of the temporal bone is extremely rare; we describe only the fourteenth reported case. Our case is further remarkable because it is the first report of such an occurrence in a patient with familial type III hyperlipoproteinemia. Moreover, while otalgia, infection, hearing loss, and tinnitus were the most common initial symptoms in the previous 13 cases, our patient reported only diplopia, vertigo, and unstable gait. The patient underwent a simple mastoidectomy and debulking, and his diplopia, vertigo, and unstable gait resolved.
Introduction
Xanthomas are soft tissue tumors composed of lipidladen tissue histiocytes. They are nonneoplastic, reactive proliferations that often occur in patients who have pathologic levels of serum lipids. Although they occasionally occur in normolipidemic patients, experimental and clinical evidence supports their increased incidence in hyperlipidemic populations. P Elevated plasma lipoprotein levels are caused by hypothyroidism, diet, insulin deficiency, alcoholism, oral contraceptive use, nephrotic syndrome, and obstructive biliary disease. In some patients, hyperlipoproteinemia is the result of a primary hereditary defect in the synthesis or degradation oflipoprotein particles. The hereditary types of hyperlipoproteinemia are familial lipoprotein lipase deficiency and/or apoprotein C-lI deficiency (type I or V), familial hypercholesterolemia (type IIa or lIb), familial dysbetalipoproteinemia (type III), familial hypertriglyceridemia (type IV), and combined hypercholesterolemia (type IIa, lIb, and/or IV) (table). ' Xanthoma formation is associated with all types of hyperlipidemia, and its severity is often determined by the severity and duration of the elevated lipid levels .'
The pathogenesis of xanthomas involves the accumulation of blood lipids in connective tissue. Serum lipoproteins escape from the vascular compartment and enter connective tissue at sites of increased vascular permeability. Tissue macrophages in the localized areas ingest the escaped particles, degrade them to lipids , and release the lipids into extracellular spaces. Undigested cholesterol builds up in crystalline form in the connective tissue and induces the inflammatory and fibrotic changes that are characteristic of the xanthomatous process .P Histologically, xanthomas appear as sheets of foamy histiocytes interspersed with inflammatory cells and extracellular cholesterol clefts.
The nidus of xanthoma formation is often a site of local trauma. Trauma can cause the release of vasoactive histamine and bradykinin, which results in increased vascular permeability. Thus, the most common sites of xanthomas are areas that typically experience repeated trauma (e.g. , the knees, elbows, and buttocks), skin that is subjected to constant creasing and folding (e.g. , the eyelids), tendons that are subjected to friction from neighboring joints, and in rare cases bone .I
The occurrence of a xanthoma in the temporal bone , which is extremely rare, is associated with the presence of hyperlipoproteinemia IIa, lIb, and VY In this article, we describe only the fourteenth reported case of a temporal bone xanthoma. What makes our case unique is that it occurred in a patient who had type III hyperlipoproteinemia.
Case report
A 28-year-old man came to our institution for an evaluation of recent-onset diplopia, vertigo, and unstable gait. The patient denied headache, hearing loss , and tinnitus. The physical examination revealed that the cranial nerves were intact. There was no nystagmus, and his extraocular movements were normal. The tymp anic membranes were clear bilaterally, and cerebellar funct ion was intact. Xanthomas were noted over the exte nsor surfaces of the hands, knee s, and buttock s. The medica l history included recurrent pancreatitis of 6 years' duration, type III hyperlipoproteinernia, and hyperuricemi a. Several years earlier, he had had a lumboperitoneal shunt placed for presumed pseudot umor cerebri and dimin ished vision in the left eye assoc iated with optic nerve atrophy. The patient ' s soc ial history was significant for smoking one pack of cigarettes per day for 10 years and drinkin g two or three beers per day. His family history was significant only for the familial type III hyperlipoproteinemi a (his father) . He had no known dru g allergies. His regular medications includ ed mecli zine and aspirin; he also reported taking gemfi brozil and pravastatin, but not on a co nsiste nt basis.
Laboratory results at the time of admission were significant for a cholesterol level of 406 mg/dl (normal: 118 to 239), a triglyceride level of2,622 mg/d l (normal: 25 to 100), and lipidemic blood . His audiogram was normal. Computed tomography revealed a soft tissue density of the righ t mastoi d and temporal bone, which was associated with significant bone destruc tion. Mag netic resonance imag ing revea led compression of the right cerebellar hemisphere, decreased flow throug h the sigmoi d sinus, and tum or extending into the middle cranial fossa toward the temporal lobe (figure I).
The patient underwent a simple mastoidectomy and debul king. Biopsy revea led that the lesion was a xanthoma (fig ure 2) . The patient did well postoperatively and reported that his diplopia, vertigo, and unstable gait had resolved . He was disch arged fro m the hospital on gemfibroz il, pravastatin, meclizine, and aspirin. When the disease does manifest, patient s typically develop palma r xanthomas, which appear as a yellowish discoloration of the hand and finger creases, and tuberous xantho mas, which are bulbous cutaneous grow ths located on the elbows and knees. In add ition, atherosclerosis involving the coro nary arteries, caro tid arteries, and the abdom inal aorta is common. Sequelae include early myocardial infarc tio n, stroke, and claudica tion of the lower extremities .' To date, xanthoma of the bone has not be en fo und in any pat ie nt with fa mili al type III hype rlipoproteinemia.
Cutaneous xanthomas usually present few diagnostic difficulties. On the other hand, deep xanthomas, which occur most ofte n in tendons or synovium but rarely in bone, pose more of a diag nostic probl em." The complexity and inaccessibility of the skull base structure make the diagnosis and treatment of lesions in this area an eve n greater challenge. Pathologic processes in this regio n can develop silently, not manifesting unt il they have reached an adva nced stage . The later stages are characterized by involvement of adjacent structures, and they can promp t In an extensive literature search, we foun d only 13
previously reporte d cases of temporal bone xanthoma.v" Otalgia, infection, hearing loss, and tin nitus were the most common initial symptoms in these 13 patients. In contrast, the patient we describe reported dip lopia, vert igo, and disequilibrium. Although hyperlipidemia was documented in approximately one -ha lf of the previously reported cases of temp oral bone xanthoma, this is the first report of an accompa ny ing famil ial ty pe III hyp erlipoproteinemia.
Because xantho mas are not true neoplasms, a conse rvative therapeutic approach is recommended. low-fat diet, co ntrol ofobes ity, and treatm ent with cholesterol-lowerin g medication s are the main stays of xanthoma managem ent. Surgical intervention is indic ated for biopsy, debulking of the mass for sy mptom relie f, and management of infecti ous co mplications. Ho wever, beca use surgically treated xantho mas tend to recur, medical therapy for hyperlipidemia should co ntinue after any surgical procedure." Th ere is little evi dence to support the benefits of radiation therapy fo r xantho mas of the tem poral bone."
